OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $38,000 | -81.6% | 22,293 | -77.2% | 0.00% | – |
| Q3 2015 | $206,000 | -82.6% | 97,735 | -59.2% | 0.00% | -100.0% |
| Q2 2015 | $1,186,000 | -81.6% | 239,648 | -70.9% | 0.00% | -80.0% |
| Q1 2015 | $6,441,000 | +44.3% | 822,562 | +11.6% | 0.01% | +66.7% |
| Q4 2014 | $4,465,000 | +3.0% | 736,821 | -27.6% | 0.01% | 0.0% |
| Q3 2014 | $4,334,000 | -17.7% | 1,017,360 | +19.4% | 0.01% | -14.3% |
| Q2 2014 | $5,267,000 | +12.4% | 852,313 | +18.2% | 0.01% | 0.0% |
| Q1 2014 | $4,687,000 | -46.2% | 721,088 | -53.4% | 0.01% | -41.7% |
| Q4 2013 | $8,716,000 | +1.5% | 1,548,176 | +10.7% | 0.01% | -14.3% |
| Q3 2013 | $8,589,000 | +5.3% | 1,398,910 | +0.3% | 0.01% | -6.7% |
| Q2 2013 | $8,156,000 | – | 1,394,277 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |